AzTrials
AzTrials

Spinal Cord InjuriesNCT06140355

cHAnging the Perceived Pain INtensity in divErSe Populations With Spinal Cord Injury

A study testing Qigong and Daily 2 min pain management survey in people with Spinal Cord Injuries, run by University of Minnesota at 3 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Chronic neuropathic pain affects 69% of adults with spinal cord injury (SCI). Current treatment options are limited (primarily pain medications) with insufficient benefits and significant risks for addiction and adverse effects. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Spinal Cord Injuries
What is being tested?
Qigong and Daily 2 min pain management survey
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
3 sitesUnited States
Study dates
20 Aug 2024to 31 Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18+ years old
  • medically stable
  • with neuropathic pain 4 or above on the numeric pain rating scale + screened with painDETECT
  • willing to participate in a remote Qigong intervention (from any location with internet connection)
  • fluent in English or Spanish
  • access to the internet and a computer/iPad or smartphone

Who cannot join

  • uncontrolled seizure disorder
  • cognitive impairment and/or communicative disability (e.g., due to brain injury) preventing them from following directions or from learning
  • ventilator dependency
  • major medical complications
  • pressure ulcers hindering prolonged sitting or lying down
  • (planning to become) pregnant or planning a major surgery during the study (given study duration, regular Qigong practice, and frequent check-ins)
  • regular Tai Chi or Qigong practice in the past 6 months (3x/week or more)
  • currently engaged in other rehabilitation programs that would influence outcomes

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Ann Van de Winckel, PhD, MSPT, PT contact

612-625-1191

avandewi@umn.edu

United States3 sites, 3 recruiting
  • University of Texas - Rio Grande Valley

    Harlingen, Texas, 78539

    Kelsey Baker, kelsey.baker@utrgv.edu

    Not yet recruiting
  • University of Miami

    Miami, Florida, 33124

    Leslie Morse

    Not yet recruiting
  • University of Minnesota

    Minneapolis, Minnesota, 55414

    Van De Winckel Van

    Recruiting

Other trials in United States

About this study

Official title: HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study

Chronic neuropathic pain affects 69% of adults with spinal cord injury (SCI). Current treatment options are limited (primarily pain medications) with insufficient benefits and significant risks for addiction and adverse effects. Of the available mind and body approaches, Qigong is the most accessible for adults with SCI with evidence for effectiveness in reducing pain, but there is insufficient evidence to make recommendations for adults with SCI. Thus, the feasibility of Qigong in SCI needs to be established.

To support our feasibility study, we investigated a 12-week remote Qigong program in adults with SCI and neuropathic pain. We recruited 23 adults with SCI, 18 completed the study, and 12 completed the 1-year follow-up. They practiced Qigong 138% of the required intensity (which was, at least 3x/week with Qigong video through the internet). Their pain was reduced by 44% after 12 weeks of Qigong practice and was still reduced at the 6-week and 1-year follow-up. However, three key elements need to be addressed before performing a larger effectiveness study: (1) feasibility/acceptability of Qigong from adults with SCI of diverse backgrounds; (2) feasibility of the study design with control group); and (3) objective outcome measures.

This R34 feasibility study, the HAPPINESS trial (cHAnging the Perceived Pain INtensity in divErSe populations with Spinal cord injury), will expand on our prior study to consolidate feasibility with a rigorous protocol. We will address the following aims: AIM 1. Identify the facilitators/barriers to participating in a Qigong study through focus groups/interviews with stakeholders from diverse backgrounds, defined as Hispanics, veterans, and adults living in rural, underserved areas. AIM 2. Establish the feasibility of study design/methods of the HAPPINESS trial in adults with SCI (at least 50% of diverse backgrounds) through pre-specified targets for recruitment/enrollment, feasibility, and acceptability of design and outcomes. Using a Phase I randomized controlled trial design, 40 adults with SCI-related neuropathic pain will be randomized to 12-week remote Qigong intervention OR a short daily pain management survey that can be completed on phone/iPad/computer + 6-month follow-up. The study results will facilitate a rigorous structure to design larger effectiveness studies and facilitate a clear pathway for researchers to investigate Qigong and other mind-body approaches for whole-person health in diverse groups of adults with chronic/neurological disorders.

Being tested
Qigong, Daily 2 min pain management survey
Medical subject headings
Spinal Cord Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QigongBehavioural

    a Qigong introduction class and a 12-week remote Qigong intervention, with a 6-month follow-up

  • Daily 2 min pain management surveyBehavioural

    Completing one short survey (2 min) daily through your phone or computer (you will get a survey link through email or text), with a 6-month follow-up.

Study groups in NCT06140355
Study groupRoleWhat they receive
Experimental groupExperimentaladults with SCI-related neuropathic pain with at least 50% from diverse groups randomized to experimental group
Receives: Behavioral: Qigong
Active comparison groupActive comparatoradults with SCI-related neuropathic pain with at least 50% from diverse groups randomized to active comparator group
Receives: Behavioral: Daily 2 min pain management survey

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. recruitment rates

    The proportion of potential participants contacted who agreed to participate

    Measured: 6 months post-intervention

  2. the recruitment rate for complete and incomplete SCI

    Ratio of complete/incomplete SCI.

    Measured: 6 months post-intervention

  3. Attrition rates in Qigong and Manage My Pain app group.

    Proportion of people withdrawing from the study in either group. Drop-out due to unrelated reasons will count as part of the general attrition.

    Measured: 6 months post-intervention

  4. intervention adherence

    the website log times will indicate the date and duration that the video is accessed. From this information, we will collect the number of minutes that they practice.

    This information will be checked with the self-report during the weekly calls, in which they will report the number of minutes per week they have practiced.

    Measured: 6 months post-intervention

  5. the frequency of use of the Manage My Pain app (recommended daily check in)

    Weekly/ monthly check-ins (reporting min/week of practice) to identify facilitators and barriers to practicing Qigong. The website logs time and duration of video access. A Qigong certified instructor will do 1:1 Qigong session with each participant via zoom monthly for quality control/to give guidance.

    Measured: 6 months post-intervention

  6. Feasibility of adhering to the collection of quantitative measure 1

    % Adherence in completing all assessments during the study and in the monthly follow-up phase

    Measured: 6 months post-intervention

  7. Feasibility of adhering to the collection of quantitative measure 2

    % Adherence to wearing Fitbit Charge 6 and sending the data through their phone App

    Measured: 6 months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2023
  2. Study start20 Aug 2024
  3. Primary completion31 Jan 2027 (estimated)
  4. Study completion31 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06140355
Sponsor's protocol ID
PT-2023-32452
Status last verified
Aug 2026
First submitted
7 Nov 2023
Last updated
19 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Van de Winckel A, Zhang L, Lim KO, Morse LR, Woodliff B, Maestre G, Baker K. Changing the Perceived Pain Intensity in Populations With Spinal Cord Injury and With Health Disparities (HAPPINESS): Protocol for a Feasibility Study. JMIR Res Protoc. 2025 Nov 19;14:e82431. doi: 10.2196/82431.

    PubMed 41259096

Questions about this trial

What is this clinical trial studying?

A study testing Qigong and Daily 2 min pain management survey in people with Spinal Cord Injuries, run by University of Minnesota at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ann Van de Winckel, PhD, MSPT, PT (612-625-1191, avandewi@umn.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

recruitment rates (time frame: 6 months post-intervention). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06140355, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in